Jesse I. Treu is 10% at Orexigen Therapeutics, Inc. (OREX). They have made 58 open-market trades across 20 companies since 2006, most recently 2019-03-26.
CIK 0001013425
25 open-market purchases totalling $108.5M since 2006, against 33 sales. Across 6 scored buys the stock is down 8.9% at ninety days, and 7.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 0% | 0% |
| Avg Move | -23.4% | -4.8% | -8.9% |
| Alpha | -18.4% | -5.0% | -7.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALDX | SELL | 2019-03-26 | 2019-03-28 | $10.01 | $1.9M | -11.3% | -11.5% | -33.6% |
| VCYT | SELL | 2019-03-04 | 2019-03-04 | $20.21 | $8.6M | +1.4% | +19.6% | +6.7% |
| VCYT | SELL | 2019-03-01 | 2019-03-04 | $20.45 | $5.6M | +1.4% | +19.6% | +6.7% |
| VCYT | SELL | 2019-02-28 | 2019-03-04 | $20.37 | $21.4M | +1.4% | +19.6% | +6.7% |
| VCYT | SELL | 2019-02-28 | 2019-03-04 | $20.50 | $7.1M | +1.4% | +19.6% | +6.7% |
| OBLN | BUY | 2018-08-23 | 2018-08-27 | $1.82 | $6.0M | +0.3% | -16.1% | -40.3% |
| VCYT | SELL | 2018-07-31 | 2018-08-02 | $10.83 | $10.8M | +3.4% | +1.8% | +27.6% |
| VCYT | SELL | 2017-05-16 | 2017-05-18 | $8.08 | $18K | -1.2% | -4.6% | -1.2% |
| EVOK | SELL | 2016-04-25 | 2016-04-27 | $5.07 | $26K | +2.5% | +13.8% | -67.4% |
| EVOK | SELL | 2015-08-18 | 2015-08-20 | $7.02 | $83K | -20.8% | -0.3% | -0.3% |
| RGDO | BUY | 2013-08-27 | 2013-08-28 | $4.00 | $3.0M | N/A | N/A | N/A |
| OCRX | BUY | 2013-07-15 | 2013-07-31 | $6.03 | $8.0M | N/A | N/A | N/A |
| ESPR | BUY | 2013-07-01 | 2013-07-02 | $14.00 | $4.0M | -35.3% | -0.8% | -0.8% |
| ALIM | SELL · 10b5-1 | 2013-06-11 | 2013-06-13 | $5.00 | $295 | -20.2% | +0.0% | +0.0% |
| CADX | SELL · 10b5-1 | 2013-04-15 | 2013-04-17 | $6.62 | $474K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-15 | 2013-03-19 | $5.23 | $3K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-15 | 2013-03-19 | $5.23 | $285K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-13 | 2013-03-15 | $5.38 | $2K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-13 | 2013-03-15 | $5.38 | $1K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-07 | 2013-03-11 | $5.25 | $3K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-03-01 | 2013-03-05 | $5.01 | $64K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-20 | 2013-02-22 | $5.01 | $31K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $5.02 | $1K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $5.02 | $65K | N/A | N/A | N/A |
| CADX | SELL · 10b5-1 | 2013-02-13 | 2013-02-15 | $5.00 | $134K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ALDX | 1,877,091 | $1.3M |
| ACHN | 159,896 | $1.1M |
| TNDM | 54,390 | $883K |
| LIFE | 13,414 | $503K |
| CLVS | 2,990,937 | $243K |
| ALIM | 40,248 | $223K |
| CLCD | 3,519 | $164K |
| AKAO | 33,890 | $4K |
| DRTX | 3,006,132 | — |
| RVA | 85,186 | — |
| SENO | 21,915 | — |
| SOMX | 53,689 | — |
| CADX | 7,313,241 | — |
| VOLC | 62,513 | — |
| RGDO | 2,571,117 | — |
| IOMI | 40,153 | — |
| NOVC | 67,875 | — |
| NSTR | 14,690 | — |
| OCRX | 1,857,036 | — |
| OREX | 50,643 | — |
| Total | $224.0M |
Shares reported on the most recent Form 4, priced at the 2019-03-28 close. 12 holdings could not be priced and are excluded from the total.